Ortega, Zoe Celestine D.
HRN: 22-79-43 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/15/2023
AMPICILLIN 500MG (VIAL)
03/15/2023
03/22/2023
IV
355mg
Q6hours
UTI; PCAP-A
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractPneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes